Next generation sequencing analysis of the postoperative tumor tissue revealed that <i>KRAS</i> copy number was increased and detected <i>SMAD4</i>, <i>RNF43</i>, and <i>PREX2</i> mutations. The gene discussed is SMAD4; the disease is neoplasm.